Why Traditional Clinical Trials Are Studying Privilege Not Medicine
We worship the "gold standard" of clinical trials, but it’s actually a wall of exclusion.
By forcing patients to travel to ivory tower sites, we’ve effectively banned 92% of the population from participating in their own survival.
Is it a "controlled environment," or just a convenient way to ignore real-world complexity?
Decentralized trials (DCTs) aren't just a tech trend. They are a dismantling of the medical gatekeeping that prioritizes investigator comfort over patient access.
We use "data burden" as an excuse to avoid the messy reality of the home. But what if the most "accurate" data is the one gathered where life actually happens?
Traditional trials fail because they measure humans in captivity, not in the wild.
If your research requires a one-hour drive and a day off work, you aren't studying medicine. You’re studying privilege.
It is time to stop asking if DCTs are "ready" and start asking why we tolerated the alternative for so long.
0
0 comments
Sterling Cooley
1
Why Traditional Clinical Trials Are Studying Privilege Not Medicine
powered by
DeSci - Decentralized Science
skool.com/desci-2718
Decentralized Science is about bringing Scientific Inventions to the Blockchain. Join to learn how to take part in this exciting field !
Build your own community
Bring people together around your passion and get paid.
Powered by